about
The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CARRole of ROS and RNS Sources in Physiological and Pathological ConditionsPromoting effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate, on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamineRegulation of aflatoxin B1-metabolizing aldehyde reductase and glutathione S-transferase by chemoprotectorsAbsence of spontaneous peroxisome proliferation in enoyl-CoA Hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolismPeroxisome proliferator-activated receptor gamma1 (PPAR-gamma1) as a major PPAR in a tissue in which estrogen induces peroxisome proliferation.Identification of cytosolic peroxisome proliferator binding protein as a member of the heat shock protein HSP70 familyPPARalpha: energy combustion, hypolipidemia, inflammation and cancerThe peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized ratsPRIC295, a Nuclear Receptor Coactivator, Identified from PPARĪ±-Interacting Cofactor ComplexInduction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE).Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis.An overview of peroxisome proliferator-induced hepatocarcinogenesis.Peroxisome proliferators and peroxisome proliferator-activated receptor alpha: biotic and xenobiotic sensingProtein profiling of mouse livers with peroxisome proliferator-activated receptor alpha activationGlutathione transferases and cancer.Changes in expression of cellular oncogenes and endogenous retrovirus-like sequences during hepatocarcinogenesis induced by a peroxisome proliferatorInduction of peroxisome proliferation and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound.Tissue distribution, excretion, and urinary metabolites of dichloroacetic acid in the male Fischer 344 rat.Cardiovascular actions of the peroxisome proliferator-activated receptor-alpha (PPARalpha) agonist Wy14,643.Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptorThe Role of NF-kappaB in PPARalpha-Mediated Hepatocarcinogenesis.Fenofibrate metabolism in the cynomolgus monkey using ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabolomics.Characterization of peroxisome proliferator-activated receptor alpha--independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor.New metabolites of fenofibrate in Sprague-Dawley rats by UPLC-ESI-QTOF-MS-based metabolomics coupled with LC-MS/MSLiver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators.Mitochondria and redox signaling in steatohepatitisCarcinogenicity of polyhalogenated biphenyls: PCBs and PBBs.Novel sequence determinants in peroxisome proliferator signaling.Differential activation of hepatic NF-kappaB in rats and hamsters by the peroxisome proliferators Wy-14,643, gemfibrozil, and dibutyl phthalate.The relevance of peroxisome proliferation and cell proliferation in peroxisome proliferator-induced hepatocarcinogenesis.Assessing human health risks from exposure to di(2-ethylhexyl)phthalate (DEHP) and related phthalates: scientific issues.Possible mechanisms in hepatocarcinogenesis by the peroxisome proliferator di(2-ethylhexyl)phthalate.A negative regulating element controlling transcription of the gene encoding acyl-CoA oxidase in Saccharomyces cerevisiae.Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence.Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene.Alterations of pancreatic hepatocytes in rats exposed to carcinogens.Sex-related difference in the inductions by perfluoro-octanoic acid of peroxisomal beta-oxidation, microsomal 1-acylglycerophosphocholine acyltransferase and cytosolic long-chain acyl-CoA hydrolase in rat liver.An in vitro demonstration of peroxisome proliferation and increase in peroxisomal beta-oxidation system mRNAs in cultured rat hepatocytes treated with ciprofibrate.Mechanism of 1,3-dichloropropene-induced rat liver carcinogenesis.
P2860
Q24554260-D849C3C6-3615-4953-8224-E91D22253B97Q26740342-BA52BCE8-3141-44C2-8FF8-805A6B49D3FEQ28329770-E852B0F6-BE00-48C0-964A-170BB7E57106Q28369729-84D7A290-2E2B-4FBA-879C-3A7804866C36Q28591221-30407A8A-575F-4AA4-89C8-E53BA968C12CQ32019780-F932BCC5-B486-4574-9E76-CBC50762ABCBQ33683291-CA3B475A-90FE-4C43-8C1F-82070AEDE137Q33805104-E0F5BD9E-74CA-49CE-A9E2-66485579DFBBQ33912894-8A013EA2-C038-488A-953B-03898096DE95Q34159503-EF5DD6F2-E598-42BF-A4CD-10468201A989Q34478999-B9C11B58-6714-4A3B-AA25-369F706ACBEAQ34841263-73C98D98-4A5B-4599-9698-FFEE6F4620DFQ35034202-462D57B0-F0D7-4FF5-AA33-4C74384841DFQ35098336-9336FF40-05CD-4C85-BF1B-BE5FF4D39C96Q35126378-6ECBCBAC-3FFD-4282-8DAB-C4985EF87949Q35815703-AB13E5DD-472C-48C1-8BCD-CA7EB5976109Q35993331-B375E9A4-7763-4439-A493-436BB4D89F47Q36465974-901CED83-36BA-4FDF-951A-C4E890B7353CQ36775059-E3E0C301-D09C-4931-8CD3-224C1B4E56CAQ36872068-59578150-3135-4373-B3F0-931C83F0CD26Q37021549-525B45CE-3B17-4E1A-A156-52D1945E156AQ37078825-C0030982-C49F-4DC9-8F88-4D0D659A71FBQ37196109-7435FCC3-59F7-4B3C-ABBC-3453E1C6E5D9Q37478119-A818456E-60DC-4C91-846C-BF9FD62218C8Q37478284-1FD53167-608C-43D9-AF5A-5AA1755621CAQ37558091-9F5513AD-F8F6-4521-B74D-D9388FAE204EQ37815476-55822483-F3F2-4C4C-B13B-A18A439443D1Q37886498-EA7ACDD9-0FB0-4705-8842-A5FAE136D0A6Q38293515-12276C8F-A48E-48BF-8E64-71248E6EC3ACQ38299929-B5636A29-869F-49C2-B018-6A3BCED42835Q38769611-03868029-98A4-4001-9BA8-7FBC7232B019Q38769618-9208F00B-BD3D-45DC-A9CF-281DF53F33D9Q38769640-575E2CE2-B9AD-4260-9E69-D0D08A15ADD4Q40423067-040F9BFA-0BF1-4483-8867-3D9CAAA5E3DDQ40976570-856A6D6F-365D-4595-AB5B-30937112AC95Q41237260-0328115F-4B62-4999-B4C9-5091E33AA269Q42050459-DCC9479A-91CA-4C51-B75A-3664163F2DC8Q42163202-6A67CCE8-220B-4088-8D72-53640D69DEC3Q42498963-3B115D81-1472-4BED-9914-A8E6620DAD27Q42703740-311BD502-EA98-4E99-95E5-FA075C1141C1
P2860
description
1987 nĆ® lÅ«n-bĆ»n
@nan
1987幓ć®č«ę
@ja
1987幓å¦ęÆęē«
@wuu
1987幓å¦ęÆęē«
@zh-cn
1987幓å¦ęÆęē«
@zh-hans
1987幓å¦ęÆęē«
@zh-my
1987幓å¦ęÆęē«
@zh-sg
1987幓åøč”ęē«
@yue
1987幓åøč”ęē«
@zh
1987幓åøč”ęē«
@zh-hant
name
Peroxisome proliferation and hepatocarcinogenesis.
@en
Peroxisome proliferation and hepatocarcinogenesis.
@nl
type
label
Peroxisome proliferation and hepatocarcinogenesis.
@en
Peroxisome proliferation and hepatocarcinogenesis.
@nl
prefLabel
Peroxisome proliferation and hepatocarcinogenesis.
@en
Peroxisome proliferation and hepatocarcinogenesis.
@nl
P356
P1433
P1476
Peroxisome proliferation and hepatocarcinogenesis.
@en
P304
P356
10.1093/CARCIN/8.5.631
P407
P577
1987-05-01T00:00:00Z